Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept

Journal of Rheumatology

Volumn 31, Issue 7, 2004, Pages 1356-1361

  Mease, Phillip J ^a,f   Ritchlin, Christopher T ^a   Martin, Richard W ^b   Gottlieb, Alice B ^c   Baumgartner, Scott W ^d   Burge, Daniel J ^e   Whitmore, James B ^e  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d Clinical Rheumatology   (United States)

^e AMGEN INC   (United States)

^f Seattle Rhumatology Associates   (United States)

Author keywords

Etanercept; Methotrexate; Pneumococcal vaccine rheumatoid arthritis

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; CORTICOSTEROID; ETANERCEPT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROVOCATION TEST; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 3042696015     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
2. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis: A randomized, controlled trial. Ann Intern Med 1999;130:478-86.
3. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
4. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.
5. Gorman JD, Sack KE, Davis JC, Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
6. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000;356:385-90.
7. Mease P, Kivitz A, Burch F, Siegel E, Cohen S, Burge D. Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial. Arthritis Rheum 2001:44; Suppl 7:S90.
8. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites DP, Abba IT, editors. Basic and clinical immunology. Norwalk, CT: Appleton and Lange; 1991:78-100.
9. Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW. Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 2002;103:13-21.
10. DeFranco AL. B-lymphocyte activation. In: Paul WE, editor. Fundamental immunology. Philadelphia: Lippincott-Raven; 1999:225-61.
11. Go ES, Ballas ZK. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 1996;98:205-15.
12. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
13. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981;3 Suppl:S184-97.
14. Jarrett MP, Schiffman G, Barland P, Grayzel AI. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum 1980;23:1287-93.
15. Elkayam O, Paran D, Caspi D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53.
16. O'Dell J, Gilg J, Palmer W, Haire C, Klassen L, Moore G. Pneumococcal vaccination: decreased antibody response in rheumatoid arthritis patients on methotrexate [abstract]. Arthritis Rheum 1992:35 Suppl 9:S197.
17. Ortqvist A. Pneumococcal vaccination: current and future issues. Eur Respir J 2001;18:184-95.
18. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318-27.
19. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003; 16:308-18.
20. Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN. Immune function and vaccine responses in healthy advanced elderly patients. Arch Inter Med 2000; 160:2017-24.